Literature DB >> 3519466

Protection of mice against lethal endotoxemia by a lipid A precursor.

R A Proctor, J A Will, K E Burhop, C R Raetz.   

Abstract

Lipid X, the major biosynthetic precursor of lipid A, has recently been described. Although lipid X is a mitogen and coagulates the Limulus amebocyte lysate, we found that it is not lethal for mice, even when given in large doses (2 X 10(6) micrograms/kg). Furthermore, lipid X was found to give partial protection against a 100% lethal dose of endotoxin, even if the lipid X was given as late as 6 h after endotoxin challenge.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519466      PMCID: PMC260947          DOI: 10.1128/iai.52.3.905-907.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

Review 1.  Bacterial endotoxins. The second Carl Prausnitz Memorial Lecture.

Authors:  O Westphal
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

2.  Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock.

Authors:  J W Holaday; A I Faden
Journal:  Nature       Date:  1978-10-05       Impact factor: 49.962

Review 3.  Treatment of gram-negative shock.

Authors:  J H Christy
Journal:  Am J Med       Date:  1971-01       Impact factor: 4.965

Review 4.  Bacterial toxins.

Authors:  L J Berry
Journal:  CRC Crit Rev Toxicol       Date:  1977-11

5.  Characterization of two membrane-associated glycolipids from an Escherichia coli mutant deficient in phosphatidylglycerol.

Authors:  M Nishijima; C R Raetz
Journal:  J Biol Chem       Date:  1981-10-25       Impact factor: 5.157

6.  Septic shock and corticosteroids.

Authors:  J N Sheagren
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

7.  Pressor effect of naloxone in septic shock.

Authors:  W P Peters; M W Johnson; P A Friedman; W E Mitch
Journal:  Lancet       Date:  1981-03-07       Impact factor: 79.321

Review 8.  Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.

Authors:  B E Kreger; D E Craven; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

9.  Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.

Authors:  E J Ziegler; J A McCutchan; J Fierer; M P Glauser; J C Sadoff; H Douglas; A I Braude
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

10.  Pulmonary pathophysiological changes in sheep caused by endotoxin precursor, lipid X.

Authors:  K E Burhop; R A Proctor; R B Helgerson; C H Raetz; J R Starling; J A Will
Journal:  J Appl Physiol (1985)       Date:  1985-12
View more
  29 in total

1.  E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide.

Authors:  T Kawata; J R Bristol; D P Rossignol; J R Rose; S Kobayashi; H Yokohama; A Ishibashi; W J Christ; K Katayama; I Yamatsu; Y Kishi
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X.

Authors:  C Lam; J Hildebrandt; E Schütze; B Rosenwirth; R A Proctor; E Liehl; P Stütz
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

Review 3.  Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.

Authors:  B Henderson; S Poole; M Wilson
Journal:  Microbiol Rev       Date:  1996-06

4.  Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide.

Authors:  K Takayama; N Qureshi; B Beutler; T N Kirkland
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

5.  Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials.

Authors:  P Y Perera; C L Manthey; P L Stütz; J Hildebrandt; S N Vogel
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Aza-lipid X.

Authors:  R L Danner; K A Joiner; J E Parrillo
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

7.  Suppression of murine endotoxin response by E5531, a novel synthetic lipid A antagonist.

Authors:  S Kobayashi; T Kawata; A Kimura; K Miyamoto; K Katayama; I Yamatsu; D P Rossignol; W J Christ; Y Kishi
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

8.  Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin.

Authors:  D T Golenbock; J A Will; C R Raetz; R A Proctor
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

9.  Free hydroxyl groups are not required for endotoxic activity of lipid A.

Authors:  K Tanamoto
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  TLR-independent induction of human monocyte IL-1 by phosphoglycolipids from thermophilic bacteria.

Authors:  Feng-Ling Yang; Kuo-Feng Hua; Yu-Liang Yang; Wei Zou; Yen-Po Chen; Shu-Mei Liang; Hsien-Yeh Hsu; Shih-Hsiung Wu
Journal:  Glycoconj J       Date:  2007-12-27       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.